Craniopharyngiomas usually present with symptoms of increased intracranial pressure such as headache, visual impairment, and endocrine deficits affecting the growth hormone (GH), luteinizing hormone (LH), follicle-stimulating hormone (FSH), thyroid-stimulating hormone (TSH), adrenocorticotropic hormone (ACTH), or antidiuretic hormone (ADH). This evidence concerns the gene AVP and craniopharyngioma.